These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 11242611)

  • 1. Leukocytoclastic vasculitis: a rare manifestation of propylthiouracil allergy.
    Casis FC; Perez JB
    Endocr Pract; 2000; 6(4):329-32. PubMed ID: 11242611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukocytoclastic vasculitis: a rare manifestation of propylthiouracil hypersensitivity.
    Erem C; Yucel Y; Ya Z; Reis A; Kocak M; Hacihasanoglu A
    Med Princ Pract; 2005; 14(5):366-9. PubMed ID: 16103706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Leukocytoclastic vasculitis as an adverse effect of propylthiouracil. A case report].
    Cortés-Guzmán JS; Veloza KT; Domínguez JD; Pinzón-Tovar A
    Rev Alerg Mex; 2023 May; 70(1):51-54. PubMed ID: 37566757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antineutrophilic cytoplasmic antibody-positive systemic vasculitis associated with propylthiouracil therapy: report of 2 children with Graves' disease.
    Poomthavorn P; Mahachoklertwattana P; Tapaneya-Olarn W; Chuansumrit A; Chunharas A
    J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1295-301. PubMed ID: 12549809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propylthiouracil-induced cutaneous vasculitis.
    Yarman S; Sandalci O; Tanakol R; Azizlerli H; Oguz H; Alagöl F
    Int J Clin Pharmacol Ther; 1997 Jul; 35(7):282-6. PubMed ID: 9247841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antineutrophil cytoplasmic antibody (ANCA)-positive cutaneous leukocytoclastic vasculitis induced by propylthiouracil confirmed by positive patch test: a case report and review of the literature.
    Morais P; Baudrier T; Mota A; Cunha AP; Alves M; Neves C; Capela J; Sá-Couto P; Azevedo F
    Cutan Ocul Toxicol; 2011 Jun; 30(2):147-53. PubMed ID: 21091384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Necrotizing vasculitis as a manifestation of hypersensitivity to propylthiouracil].
    Dinato SL; Dinato MC; Dinato MM; Ribeiro MC; Yamashiro CY; Romiti N
    Arq Bras Endocrinol Metabol; 2009 Apr; 53(3):374-7. PubMed ID: 19578601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent episodes of arthritis in a hyperthyroid patient.
    Tan F; Nam TQ; Lee KO; Cheah WK; Mukherjee JJ
    Singapore Med J; 2006 Feb; 47(2):163-5. PubMed ID: 16435062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of propylthiouracil on subsequent radioactive iodine therapy in Graves' disease.
    Hancock LD; Tuttle RM; LeMar H; Bauman J; Patience T
    Clin Endocrinol (Oxf); 1997 Oct; 47(4):425-30. PubMed ID: 9404440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propylthiouracil-Associated Leukocytoclastic Necrotizing Cutaneous Vasculitis: A Case Report and Review of the Literature.
    Wall AE; Weaver SM; Litt JS; Rae L
    J Burn Care Res; 2017; 38(3):e678-e685. PubMed ID: 27893578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propylthiouracil-induced hypersensitivity vasculitis presenting as respiratory failure.
    Stankus SJ; Johnson NT
    Chest; 1992 Nov; 102(5):1595-6. PubMed ID: 1424898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTU-associated cutaneous vasculitis with ANCA anti-MPO and anti-PR3 antibodies.
    Jacobs EM; Hartkamp A; Kaasjager HA
    Neth J Med; 2003 Sep; 61(9):296-9. PubMed ID: 14692444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous vasculitis associated with propylthiouracil therapy.
    Carrasco MD; Riera C; Clotet B; Grifol M; Foz M
    Arch Intern Med; 1987 Sep; 147(9):1677. PubMed ID: 3632175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antineutrophil cytoplasmic antibody (ANCA)-positive cutaneous leucocytoclastic vasculitis associated with antithyroid therapy in Graves' disease.
    Miller RM; Savige J; Nassis L; Cominos BI
    Australas J Dermatol; 1998 May; 39(2):96-9. PubMed ID: 9611379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propylthiouracil-induced cutaneous vasculitis. Case presentation and review of the literature.
    Vasily DB; Tyler WB
    JAMA; 1980 Feb; 243(5):458-61. PubMed ID: 6892530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of standardized initial doses of two antithyroid drugs in the treatment of Graves' disease.
    Kallner G; Vitols S; Ljunggren JG
    J Intern Med; 1996 Jun; 239(6):525-9. PubMed ID: 8656146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propylthiouracil hypersensitivity: report of two patients with vasculitis and review of the literature.
    Chastain MA; Russo GG; Boh EE; Chastain JB; Falabella A; Millikan LE
    J Am Acad Dermatol; 1999 Nov; 41(5 Pt 1):757-64. PubMed ID: 10534640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perinuclear antineutrophil cytoplasmic antibody-associated vasculitis in a patient with Graves' disease treated with methimazole.
    Bilu Martin D; Deng A; Gaspari A; Pearson F
    Skinmed; 2006; 5(6):302-5. PubMed ID: 17086001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preserved activation of thyrotropin receptor antibody to stimulate thyroid function despite long-term treatment in euthyroid patients with Graves' disease.
    Akuzawa M; Murakami M; Yamada M; Satoh T; Shimizu H; Mori M
    Eur J Endocrinol; 1998 Mar; 138(3):281-5. PubMed ID: 9539302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A fatal case of propylthiouracil-induced ANCA-associated vasculitis resulting in rapidly progressive glomerulonephritis, acute hepatic failure, and cerebral angiitis.
    Khan TA; Yin Luk FC; Uqdah HT; Arif A; Hussain H; Jayatilleke A; Aggarwal S
    Clin Nephrol; 2015 May; 83(5):309-14. PubMed ID: 25208313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.